SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form CERTNAS - Certification by the Nasdaq Stock Market approving securities for listing:
SEC Accession No. 9999999997-17-007272
Filing Date
2017-06-26
Accepted
2017-06-26 13:15:52
Documents
1
Effectiveness Date
2017-06-26

Document Format Files

Seq Description Document Type Size
1 AUTO-GENERATED PAPER DOCUMENT 9999999997-17-007272.paper CERTNAS 294
  Scanned paper document scanned.pdf   197541
  Complete submission text file 9999999997-17-007272.txt   1377
Mailing Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139 617-498-0020
Mersana Therapeutics, Inc. (Filer) CIK: 0001442836 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CERTNAS | Act: 34 | File No.: 001-38129 | Film No.: 17010594
SIC: 2834 Pharmaceutical Preparations